Research
Analyst Biographies - Health Care
| Christine Arnold Managing Director (646) 562-1322 christine.arnold@cowen.com Prior to joining Cowen and Company in January 2009, Christine Arnold spent more than eight years at Morgan Stanley, where she covered health care services stocks. Prior to that, she was a coverage analyst at UBS and Goldman Sachs. Ms. Arnold has ranked highly in a variety of polls, including Greenwich and Forbes. She holds a B.A. in business and finance from Georgetown University. Health Care |
| Ken Cacciatore Managing Director (646) 562-1305 ken.cacciatore@cowen.com Ken Cacciatore is a Managing Director and Senior Research Analyst in the pharmaceutical research group. Mr. Cacciatore joined the Cowen pharmaceutical research team in June 2000. Previously, Mr. Cacciatore worked in Cowen's health care investment banking department. He graduated from Lafayette College with a degree in economics and received an M.B.A. from the Anderson School at UCLA. Health Care |
| Sara Michelmore Managing Director (646) 562-1334 sara.michelmore@cowen.com Sara Michelmore is a Managing Director and Senior Research Analyst in the medical technology group, specializing in the hospital supply/diversified, diagnostics, and lab equipment industries. Ms. Michelmore has been at Cowen since 1999 in positions of increasing responsibility. Prior to Cowen, Ms. Michelmore was a research associate at the former Warburg Dillon Read LLC (now UBS) in the medical technology group. Prior to that, she served as a senior account executive for Feinstein Kean Partners, specializing in investor relations for biotechnology and medical device companies and was a senior market analyst with Boston Biomedical Consultants, a strategic consulting and market research firm for the diagnostics industry. Ms. Michelmore has an A.B. in biochemistry, cum laude, from Bowdoin College, where she also minored in economics. Health Care |
| Phil Nadeau Managing Director (646) 562-1336 phil.nadeau@cowen.com Philip Nadeau is a Managing Director and Senior Research Analyst on the biotechnology team at Cowen and Company. He has been at Cowen for ten years, and is responsible for covering 20 large-, mid-, and small- cap biotechnology stocks. He has been recognized in the Wall Street Journals Best on the Street rankings, and his views on biotechnology topics are often quoted by national news services such as Reuters, Bloomberg news, and the Dow Jones Newswires. Prior to joining Cowen, he was a research assistant at Childrens Hospital, Boston. Mr. Nadeau has a Ph.D. in neurobiology from Harvard University and an S.B./M.Eng in electrical engineering and computer science from MIT Health Care |
| Ian Sanderson Managing Director (617) 946-3922 ian.sanderson@cowen.com Ian Sanderson is a Senior Research Analyst covering emerging and mid-cap pharmaceutical companies for Cowen, including specialty pharmaceutical, drug delivery, and generic pharmaceutical companies. He has been a pharmaceuticals analyst at Cowen since 1992. His prior experience includes investment banking at Cowen and Houlihan Lokey Howard & Zukin; securities analysis at Cambridge Associates and Putnam International Advisors; and systems design at U.S. Surgical Corporation. He received a B.A., political economy, from Williams College and an M.B.A., finance, from the Wharton School at the University of Pennsylvania. Health Care |
| Steve Scala Managing Director (617) 946-3923 steve.scala@cowen.com Steve Scala is a Senior Research Analyst with more than 15 years of experience following the pharmaceutical industry, including large-, mid- and small-cap companies. He has been a runner-up numerous times in Major Pharmaceuticals in the Institutional Investor survey. Prior to joining Cowen, Mr. Scala was a pharmacist at New England Medical Center in Boston. He received a B.S. in pharmacy from the University of Connecticut, an M.S. in pharmacy from Ohio State University, and an M.B.A. from Bentley College. He is a CFA charterholder. Health Care |
| Doug Schenkel Managing Director (617) 946-3918 doug.schenkel@cowen.com Doug Schenkel is a Managing Director and Senior Research Analyst in the medical technology research group, specializing in the life science tools, diagnostics, medical equipment, orthopedics and spine industries. Prior to joining Cowen's medical supplies and devices team in 2005, Doug Schenkel was a vice president with Global Biomedical Partners, managing a life science cross-over fund. Mr. Schenkel previously worked in private equity with Triumph Capital Group and started his career with Cowen & Company in the health care investment banking group. He has an M.B.A. from the UCLA Anderson School of Business and a B.S. in business administration from Georgetown University. Health Care |
| Eric Schmidt Managing Director (646) 562-1345 eric.schmidt@cowen.com Eric Schmidt is a Managing Director and Senior Research Analyst. He covers over 20 large-, mid-, and small-cap biotechnology stocks. Mr. Schmidt has been recognized in polls conducted by Alpha Magazine, Institutional Investor, Reuters, and The Wall Street Journal. Prior to joining Cowen in 1998 he was a vice president covering the biotechnology sector for UBS Securities. He holds a B.A. in chemistry from the University of Pennsylvania and a Ph.D. in biochemistry from the Massachusetts Institute of Technology. Health Care |
